Li, J., Wang, R., Chen, J., Xu, A., Fu, Y., Lin, Y., . . . Fu, Q. (2025). Efficacy and safety of ruxolitinib in adult patients with refractory rheumatic disease-associated macrophage activation syndrome. Frontiers Media S.A.
Chicago Style (17th ed.) CitationLi, Jingjing, et al. Efficacy and Safety of Ruxolitinib in Adult Patients with Refractory Rheumatic Disease-associated Macrophage Activation Syndrome. Frontiers Media S.A, 2025.
MLA (9th ed.) CitationLi, Jingjing, et al. Efficacy and Safety of Ruxolitinib in Adult Patients with Refractory Rheumatic Disease-associated Macrophage Activation Syndrome. Frontiers Media S.A, 2025.
Warning: These citations may not always be 100% accurate.